Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-04634817 vs Ranibizumab in Diabetic Macular Edema
NCT01994291Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Nov 2013
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of PF-04634817 in diabetic macular edema (DME), sponsored by Pfizer. Started Nov 2013; status: terminated.
02
Drugs
PF-04634817
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01994291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01994291.